LEADER 06775nam 2201825z- 450 001 9910557780703321 005 20231214133648.0 035 $a(CKB)5400000000045582 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68697 035 $a(EXLCZ)995400000000045582 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$a3D Printing of Pharmaceuticals and Drug Delivery Devices 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 electronic resource (436 p.) 311 $a3-03936-423-5 311 $a3-03936-424-3 330 $aThe 3D printing (3DP) process was patented in 1986; however, only in the last decade has it begun to be used for medical applications, as well as in the fields of prosthetics, bio-fabrication, and pharmaceutical printing. 3DP or additive manufacturing (AM) is a family of technologies that implement layer-by-layer processes in order to fabricate physical models based on a computer aided design (CAD) model. 3D printing permits the fabrication of high degrees of complexity with great reproducibility in a fast and cost-effective fashion. 3DP technology offers a new paradigm for the direct manufacture of individual dosage forms and has the potential to allow for variations in size and geometry as well as control dose and release behavior. Furthermore, the low cost and ease of use of 3DP systems means that the possibility of manufacturing medicines and medical devices at the point of dispensing or at the point of use could become a reality. 3DP thus offers the perfect innovative manufacturing route to address the critical capability gap that hinders the widespread exploitation of personalized medicines for molecules that are currently not easy to deliver. This Special Issue will address new developments in the area of 3D printing and bioprinting for drug delivery applications, covering the recent advantages and future directions of additive manufacturing for pharmaceutical products. 606 $aMedicine$2bicssc 610 $adigital pharmacy 610 $afused deposition modeling 3D printing 610 $amodified drug release 610 $apersonalized medicines 610 $atelemedicine 610 $athree dimensional printing 610 $aadditive manufacturing 610 $a3D printed drug products 610 $aprintlets 610 $apersonalised medicines 610 $apersonalized pharmaceuticals 610 $amultiple units 610 $aspheroids 610 $abeads 610 $aacetaminophen 610 $a3D printing 610 $afused filament fabrication 610 $alignin 610 $aantioxidant materials 610 $awound dressing 610 $amodified release 610 $afilament extrusion 610 $afused layer modeling 610 $atheophylline 610 $ahigh API load 610 $athree-dimensional printing 610 $afixed-dose combinations 610 $atablets 610 $amultiple-layer dosage forms 610 $astereolithography 610 $avat polymerisation 610 $afused deposition modeling 610 $apolylactic acid 610 $achemical modification 610 $aMTT assay 610 $abiofilm formation 610 $awarfarin 610 $asemisolid extrusion 3D printing 610 $ainkjet printing 610 $aorodispersible film 610 $aoral powder 610 $apediatric 610 $ahospital pharmacy 610 $apersonalized medicine 610 $aon-demand manufacturing 610 $adrug delivery 610 $amicromedicine 610 $adrug development 610 $amicro-swimmer 610 $amicro-implant 610 $aoral dosages 610 $amicroneedle 610 $ahigh-precision targeting 610 $acontrolled release 610 $ageometry 610 $aresolution 610 $afeature size 610 $arelease profile 610 $avascularization 610 $adigital light processing technology 610 $aneural networks 610 $aoptimization 610 $aprediction 610 $aFMD 610 $apregabalin 610 $agastric floating 610 $acomplex structures 610 $apatient-specific 610 $astructural design 610 $agums 610 $aFused Deposition Modeling 3D Printing 610 $aprocessing parameters 610 $apharmaceutical quality control 610 $ahot-melt extrusion 610 $asolid dosage forms 610 $a3D printed oral dosage forms 610 $asustained drug release tablets 610 $aphotopolymerization 610 $aparacetamol (acetaminophen) 610 $aaspirin (acetylsalicylic acid) 610 $aamorphous solid dispersion 610 $apoor solubility 610 $afixed dose combination 610 $astencil printing 610 $apharmacoprinting 610 $aorodispersible discs 610 $aorodisperible films 610 $afloating systems 610 $apulsatile release 610 $achronotherapeutic delivery 610 $awound-healing 610 $a3D bio-printing 610 $apectin 610 $apropolis 610 $acyclodextrin 610 $a3D bio-inks 610 $afused deposition modelling 610 $aextrusion 610 $avaginal meshes 610 $amechanical properties 610 $adrug release 610 $aanti-infective devices 610 $apelvic organ prolapse 610 $astress urinary incontinence 610 $agastro-retentive floating system 610 $adissolution kinetics 610 $aimplantable devices 610 $asubcutaneous 610 $abiodegradable 610 $aprolonged drug delivery 610 $apolymers 610 $apharmaceuticals 610 $aextrusion-based 3D printing 610 $afused deposition modeling (FDM) 610 $apressure-assisted microsyringe (PAM) 610 $amaterials 610 $aprocess 610 $a3D bioprinting 610 $apolymeric ink 610 $apseudo-bone 610 $aimplantable scaffold 610 $acomputer-aided design (CAD) design 610 $abioprinting 610 $acomputer-aided design (CAD) 610 $apharmaceutics 615 7$aMedicine 700 $aLamprou$b Dimitrios A$4edt$01303399 702 $aLamprou$b Dimitrios A$4oth 906 $aBOOK 912 $a9910557780703321 996 $a3D Printing of Pharmaceuticals and Drug Delivery Devices$93026998 997 $aUNINA